Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2010 2
2011 3
2013 2
2014 2
2015 3
2016 2
2017 2
2018 4
2019 3
2020 3
2021 1
2022 2
2023 1
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean windemuth kiesselbach c (2 results)?
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Livingstone E, Zimmer L, Hassel JC, Fluck M, Eigentler TK, Loquai C, Haferkamp S, Gutzmer R, Meier F, Mohr P, Hauschild A, Schilling B, Menzer C, Kiecker F, Dippel E, Roesch A, Ziemer M, Conrad B, Körner S, Windemuth-Kieselbach C, Schwarz L, Garbe C, Becker JC, Schadendorf D; Dermatologic Cooperative Oncology Group. Livingstone E, et al. Among authors: windemuth kieselbach c. Lancet. 2022 Oct 1;400(10358):1117-1129. doi: 10.1016/S0140-6736(22)01654-3. Epub 2022 Sep 10. Lancet. 2022. PMID: 36099927 Clinical Trial.
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints.
Puntmann VO, Beitzke D, Kammerlander A, Voges I, Gabbert DD, Doerr M, Chamling B, Bozkurt B, Kaski JC, Spatz E, Herrmann E, Rohde G, DeLeuw P, Taylor L, Windemuth-Kieselbach C, Harz C, Santiuste M, Schoeckel L, Hirayama J, Taylor PC, Berry C, Nagel E. Puntmann VO, et al. Among authors: windemuth kieselbach c. J Cardiovasc Magn Reson. 2025 Summer;27(1):101121. doi: 10.1016/j.jocmr.2024.101121. Epub 2024 Oct 29. J Cardiovasc Magn Reson. 2025. PMID: 39481808 Free PMC article.
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial.
Becker JC, Gesierich AH, Leiter U, Zimmer L, Hassel JC, von Wasielewski I, Ziemer M, Fluck M, Meier F, Spillner AN, Schilling B, Eigentler TK, Livingstone E, Ugurel S, Angela Y, Windemuth-Kieselbach C, Gutzmer R. Becker JC, et al. Among authors: windemuth kieselbach c. Br J Dermatol. 2025 Jul 26:ljaf303. doi: 10.1093/bjd/ljaf303. Online ahead of print. Br J Dermatol. 2025. PMID: 40713865
Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.
Livingstone E, Gogas H, Kandolf-Sekulovic L, Meier F, Eigentler TK, Ziemer M, Terheyden PAM, Gesierich AH, Herbst RA, Kähler KC, Ziogas DC, Mijuskovic Z, Garzarolli M, Garbe C, Roesch A, Ugurel S, Gutzmer R, Grob JJ, Kiecker F, Utikal J, Windemuth-Kieselbach C, Eckhardt S, Zimmer L, Schadendorf D. Livingstone E, et al. Among authors: windemuth kieselbach c. Eur J Cancer. 2023 Sep;190:112941. doi: 10.1016/j.ejca.2023.112941. Epub 2023 Jun 15. Eur J Cancer. 2023. PMID: 37482012 Clinical Trial.
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.
Hofheinz RD, Anchisi S, Grünberger B, Derigs HG, Zahn MO, Geffriaud-Ricouard C, Gueldner M, Windemuth-Kieselbach C, Pederiva S, Bohanes P, Scholten F, Piringer G, Thaler J, von Moos R. Hofheinz RD, et al. Among authors: windemuth kieselbach c. Cancers (Basel). 2022 Jul 20;14(14):3522. doi: 10.3390/cancers14143522. Cancers (Basel). 2022. PMID: 35884583 Free PMC article.
Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12.
Romanos M, Freitag C, Jacob C, Craig DW, Dempfle A, Nguyen TT, Halperin R, Walitza S, Renner TJ, Seitz C, Romanos J, Palmason H, Reif A, Heine M, Windemuth-Kieselbach C, Vogler C, Sigmund J, Warnke A, Schäfer H, Meyer J, Stephan DA, Lesch KP. Romanos M, et al. Among authors: windemuth kieselbach c. Mol Psychiatry. 2008 May;13(5):522-30. doi: 10.1038/mp.2008.12. Epub 2008 Feb 26. Mol Psychiatry. 2008. PMID: 18301393
Gene expression profiling at birth characterizing the preterm infant with early onset infection.
Hilgendorff A, Windhorst A, Klein M, Tchatalbachev S, Windemuth-Kieselbach C, Kreuder J, Heckmann M, Gkatzoflia A, Ehrhardt H, Mysliwietz J, Maier M, Izar B, Billion A, Gortner L, Chakraborty T, Hossain H. Hilgendorff A, et al. Among authors: windemuth kieselbach c. J Mol Med (Berl). 2017 Feb;95(2):169-180. doi: 10.1007/s00109-016-1466-4. Epub 2016 Aug 30. J Mol Med (Berl). 2017. PMID: 27576916 Free PMC article.
Association and linkage of allelic variants of the dopamine transporter gene in ADHD.
Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M, Freitag C, Seitz C, Palmason H, Scherag A, Windemuth-Kieselbach C, Schimmelmann BG, Wewetzer C, Meyer J, Warnke A, Lesch KP, Reinhardt R, Herpertz-Dahlmann B, Linder M, Hinney A, Remschmidt H, Schäfer H, Konrad K, Hübner N, Hebebrand J. Friedel S, et al. Among authors: windemuth kieselbach c. Mol Psychiatry. 2007 Oct;12(10):923-33. doi: 10.1038/sj.mp.4001986. Epub 2007 Apr 10. Mol Psychiatry. 2007. PMID: 17579611
31 results